Fertility Associates Limited

Fertility Associates Limited provides specialized fertility treatments, focusing on In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) to assist individuals and couples facing infertility challenges, including LGBTQIA+ families. Fertility Associates Limited, founded in 1987, is based in Auckland, New Zealand. The company specializes in fertility treatments and has established a strong reputation in the industry. In December 2021, a consortium comprising Comprador Holdings, New Zealand Superannuation Fund, and Pioneer Capital Partners acquired a 70% majority stake in the company.

The firm has been involved in a total of 1 deal as of its most recent deal on December 20, 2021. Fertility Associates specializes in a comprehensive range of fertility treatments, including In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and Ovulation Induction (OI). Their core offerings are designed to address various causes of infertility in both men and women, providing tailored solutions to meet individual needs. IVF treatments are conducted under well-controlled conditions to optimize the chances of conception, while IUI serves as a less invasive option for couples facing specific infertility challenges.

The company has established a solid reputation in the fertility industry, with services available across New Zealand and extending to international clients seeking advanced reproductive assistance. Clients include couples and individuals from diverse backgrounds, including those seeking donor options and LGBTQIA+ families. The clinics are strategically located nationwide, ensuring accessibility to a broad clientele seeking fertility solutions. Fertility Associates generates revenue through a structured fee-for-service model, where clients pay for individual treatments and consultations.

The company's services are priced according to the complexity of each procedure, encompassing initial fertility assessments, ongoing treatment plans, and additional technology enhancements. Transactions are typically direct to consumer, engaging clients who seek personalized fertility solutions. Key services, such as IVF and IUI, form the cornerstone of the revenue stream, driven by recognized success rates and quality of care. Following the acquisition in December 2021, Fertility Associates Limited plans to utilize the investment to support the expansion of its services in Malaysia and selectively into other Asia-Pacific countries.

The company aims to enhance its service offerings and reach a broader audience in these new markets.